Your browser doesn't support javascript.
loading
Intravenous lipo-prostaglandin E1 administration for patients with acute central retinal artery occlusion.
Suzuki, Takafumi; Obata, Ryo; Inoue, Tatsuya; Ueta, Yoshiki; Azuma, Keiko; Tate, Hideo; Kitamoto, Kohdai; Otaki, Chisato; Hashimoto, Yoshihiro; Aihara, Makoto; Tachi, Naoko.
Afiliação
  • Suzuki T; Shinseikai Toyama Hospital, Imizu, Toyama, Japan.
  • Obata R; The University of Tokyo Hospital, Bunkyo-ku, Japan.
  • Inoue T; The University of Tokyo Hospital, Bunkyo-ku, Japan robata-tky@umin.ac.jp.
  • Ueta Y; The University of Tokyo Hospital, Bunkyo-ku, Japan.
  • Azuma K; Yokohama City University, Yokohama, Kanagawa, Japan.
  • Tate H; Shinseikai Toyama Hospital, Imizu, Toyama, Japan.
  • Kitamoto K; The University of Tokyo Hospital, Bunkyo-ku, Japan.
  • Otaki C; Shinseikai Toyama Hospital, Imizu, Toyama, Japan.
  • Hashimoto Y; The University of Tokyo Hospital, Bunkyo-ku, Japan.
  • Aihara M; Shinseikai Toyama Hospital, Imizu, Toyama, Japan.
  • Tachi N; Shinseikai Toyama Hospital, Imizu, Toyama, Japan.
BMJ Open Ophthalmol ; 7(1)2022 05.
Article em En | MEDLINE | ID: mdl-36161847

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alprostadil / Oclusão da Artéria Retiniana Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alprostadil / Oclusão da Artéria Retiniana Idioma: En Ano de publicação: 2022 Tipo de documento: Article